Related Experiment Video

Updated: Oct 4, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

28.1K

Spinal aspergillosis: a rare complication of COVID-19 infection

Rumana Makhdoomi1, Nayil Malik2, Jagdish Charan2

  • 1Department of Pathology, Sheri-Kashmir-Institute of Medical Sciences, Srinagar, Kashmir 190011 India.

Egyptian Journal of Neurosurgery
|February 2, 2022
PubMed
Abstract

Insights

A rare case of Spinal Aspergillosis, a secondary fungal infection, is presented in an 85-year-old male seven months post-COVID-19. This condition can manifest as cauda equina syndrome, requiring prompt diagnosis and treatment.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Mycology

Background:

  • COVID-19 is associated with various complications, frequently including secondary infections.
  • Fungal infections, though less common, can occur post-COVID-19.

Observation:

  • An 85-year-old male developed cauda equina syndrome seven months after contracting COVID-19.
  • An extradural mass was surgically removed.
  • Pathological examination revealed the mass to be Spinal Aspergillosis.

Findings:

  • Spinal Aspergillosis can present as a delayed complication following COVID-19 infection.
  • Cauda equina syndrome may be a presenting neurological deficit.

Implications:

  • Clinicians should consider Spinal Aspergillosis in post-COVID-19 patients with spinal symptoms.
  • Early recognition and treatment of fungal spinal infections are crucial for favorable outcomes.
Keywords:
COVID-19Fungal infectionSpinal Aspergillosis

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.7K
Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung15:01

Confocal Laser Scanning Microscopy-Based Quantitative Analysis of Aspergillus fumigatus Conidia Distribution in Whole-Mount Optically Cleared Mouse Lung

Published on: September 18, 2021

3.5K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
510
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
901
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
372
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
379
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
667
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
930